Streetbeat News

MRAI

Marpai Inc

Employees

marpai health is working at the intersection of healthcare and deep learning, the most advanced form of artificial intelligence. our mission is to predict and prevent costly events in healthcare for the benefit of patients, providers and payors.

Open

1.40

Mkt cap

18M

Volume

4.8K

High

1.40

P/E Ratio

-0.45

52-wk high

2.96

Low

1.13

Div yield

N/A

52-wk low

0.40

Marpai, Inc. announced a private placement of 621,194 shares of its Class A common stock at $1.13 per share, raising approximately $701,950. This move is part of its strategy to transform the TPA market with affordable healthcare solutions.

Portfolio Pulse from

December 05, 2024 | 9:30 pm

Marpai, Inc. (OTCQX: MRAI) has announced securing significant new accounts for 2025, indicating potential growth and expansion in its operations as a national Third-Party Administrator.

Portfolio Pulse from

November 26, 2024 | 11:00 pm

Marpai, Inc (MRAI) held its Q3 2024 earnings call, discussing financial results and company updates.

Portfolio Pulse from

November 12, 2024 | 7:15 pm

Marpai, Inc. (OTCQX: MRAI) reported its financial results for the third quarter of 2024, highlighting continued progress in its turnaround strategy. The company operates as a national Third-Party Administrator, providing intelligent healthcare solutions to self-funded employer health plans.

Portfolio Pulse from

November 11, 2024 | 9:30 pm

Marpai, Inc. (OTCQX: MRAI) will host a webcast on November 12, 2024, to discuss its third-quarter 2024 financial results. Marpai operates as a national Third-Party Administrator through its subsidiaries.

Portfolio Pulse from

November 08, 2024 | 8:00 pm

Marpai (NASDAQ:MRAI) reported a Q3 GAAP EPS of $(1.23), down from $(1.10) YoY, and sales of $7.19M, down from $10.05M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 9:03 pm

Shares of Applied DNA Sciences (APDN) fell sharply by 67.5% after announcing a $12 million public offering. Other notable stock movements include Sharps Technology (STSS) climbing 207%, Insmed Incorporated (INSM) jumping 110% on positive Phase 3 study results, and Pineapple Energy (PEGY) gaining 91.5% after a subsidiary signed a significant project. Several other stocks experienced significant gains and losses during Tuesday's mid-day session.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 5:24 pm

U.S. stocks traded mixed with the Dow Jones falling over 100 points, while the NASDAQ and S&P 500 saw gains. GameStop shares spiked 24% after completing an equity offering. Insmed, Calliditas Therapeutics, and Pineapple Energy saw significant gains, while Applied DNA Sciences, Marpai, and Netcapital experienced sharp declines.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 4:00 pm

US stocks showed mixed performance with the Dow Jones falling, while the NASDAQ rose slightly. The S&P CoreLogic Case-Shiller home price index increased by 7.4% year-over-year in March. Notable stock movements included significant gains for Sharps Technology, Insmed Incorporated, and Pineapple Energy, while Applied DNA Sciences, Marpai, and Innovative Eyewear saw substantial declines.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 2:05 pm

Marpai shares are trading lower after the company announced its intention to withdraw from the Nasdaq hearings process.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 1:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.